R2

Prostate Cancer Treatment Is Creating a Metabolic Bill

Parkinson’s Gets a Cleaner Dopamine Bet

Myasthenia Care Cannot Wait for Crisis

Do patients need maximum-dose tirzepatide forever? New data suggest a middle ground

Bladder Cancer Is Moving Into the Immunotherapy Maintenance Era

Duchenne’s Cell Therapy Gets More Time, Not Certainty

C. Diff Can Hide in Plain Sight.

WHO Rewrote the Typhoid Playbook

Tourette Care Has Waited Too Long
Free IPM Alliance Newsletter
Insights on science, policy and access in personalised medicine.
